Pharma Mar SA
MAD:PHM

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
MAD:PHM
Watchlist
Price: 82 EUR 0.06%
Market Cap: 1.5B EUR

Wall Street
Price Targets

PHM Price Targets Summary
Pharma Mar SA

Wall Street analysts forecast PHM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHM is 95.88 EUR with a low forecast of 30.3 EUR and a high forecast of 123.9 EUR.

Lowest
Price Target
30.3 EUR
63% Downside
Average
Price Target
95.88 EUR
17% Upside
Highest
Price Target
123.9 EUR
51% Upside
Pharma Mar SA Competitors:
Price Targets
MRNA
Moderna Inc
48% Upside
005690
Pharmicell Co Ltd
25% Upside
MGX
Metagenomi Inc
415% Upside
301080
Acrobiosystems Co Ltd
20% Downside
VRTX
Vertex Pharmaceuticals Inc
11% Upside
4893
Noile-Immune Biotech Inc
158% Upside
214450
PharmaResearch Co Ltd
7% Downside
RCUS
Arcus Biosciences Inc
205% Upside

Revenue
Forecast

Revenue Estimate
Pharma Mar SA

For the last 8 years the compound annual growth rate for Pharma Mar SA's revenue is 0%. The projected CAGR for the next 3 years is 26%.

0%
Past Growth
26%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Pharma Mar SA

The compound annual growth rate of Pharma Mar SA's operating income for the next 3 years is 190%.

N/A
Past Growth
190%
Estimated Growth
Estimates Accuracy
18%
Average Beat

Net Income
Forecast

Net Income Estimate
Pharma Mar SA

The compound annual growth rate of Pharma Mar SA's net income for the next 3 years is 53%.

N/A
Past Growth
53%
Estimated Growth
Estimates Accuracy
20%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHM's stock price target?
Price Target
95.88 EUR

According to Wall Street analysts, the average 1-year price target for PHM is 95.88 EUR with a low forecast of 30.3 EUR and a high forecast of 123.9 EUR.

What is Pharma Mar SA's Revenue forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Pharma Mar SA's revenue is 0%. The projected CAGR for the next 3 years is 26%.

What is Pharma Mar SA's Operating Income forecast?
Projected CAGR
190%

The compound annual growth rate of Pharma Mar SA's operating income for the next 3 years is 190%.

What is Pharma Mar SA's Net Income forecast?
Projected CAGR
53%

The compound annual growth rate of Pharma Mar SA's net income for the next 3 years is 53%.

Back to Top